290 related articles for article (PubMed ID: 23292638)
1. Novel mutations mapping to the fourth sodium channel domain of Nav1.7 result in variable clinical manifestations of primary erythromelalgia.
Cregg R; Laguda B; Werdehausen R; Cox JJ; Linley JE; Ramirez JD; Bodi I; Markiewicz M; Howell KJ; Chen YC; Agnew K; Houlden H; Lunn MP; Bennett DL; Wood JN; Kinali M
Neuromolecular Med; 2013 Jun; 15(2):265-78. PubMed ID: 23292638
[TBL] [Abstract][Full Text] [Related]
2. Inherited pain: sodium channel Nav1.7 A1632T mutation causes erythromelalgia due to a shift of fast inactivation.
Eberhardt M; Nakajima J; Klinger AB; Neacsu C; Hühne K; O'Reilly AO; Kist AM; Lampe AK; Fischer K; Gibson J; Nau C; Winterpacht A; Lampert A
J Biol Chem; 2014 Jan; 289(4):1971-80. PubMed ID: 24311784
[TBL] [Abstract][Full Text] [Related]
3. Novel SCN9A mutations underlying extreme pain phenotypes: unexpected electrophysiological and clinical phenotype correlations.
Emery EC; Habib AM; Cox JJ; Nicholas AK; Gribble FM; Woods CG; Reimann F
J Neurosci; 2015 May; 35(20):7674-81. PubMed ID: 25995458
[TBL] [Abstract][Full Text] [Related]
4. A novel SCN9A mutation responsible for primary erythromelalgia and is resistant to the treatment of sodium channel blockers.
Wu MT; Huang PY; Yen CT; Chen CC; Lee MJ
PLoS One; 2013; 8(1):e55212. PubMed ID: 23383113
[TBL] [Abstract][Full Text] [Related]
5. The Domain II S4-S5 Linker in Nav1.9: A Missense Mutation Enhances Activation, Impairs Fast Inactivation, and Produces Human Painful Neuropathy.
Han C; Yang Y; de Greef BT; Hoeijmakers JG; Gerrits MM; Verhamme C; Qu J; Lauria G; Merkies IS; Faber CG; Dib-Hajj SD; Waxman SG
Neuromolecular Med; 2015 Jun; 17(2):158-69. PubMed ID: 25791876
[TBL] [Abstract][Full Text] [Related]
6. A new Nav1.7 mutation in an erythromelalgia patient.
Estacion M; Yang Y; Dib-Hajj SD; Tyrrell L; Lin Z; Yang Y; Waxman SG
Biochem Biophys Res Commun; 2013 Mar; 432(1):99-104. PubMed ID: 23376079
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of a chronic pain mutation in the voltage-gated sodium channel Nav1.7 increases voltage sensitivity.
Kerth CM; Hautvast P; Körner J; Lampert A; Meents JE
J Biol Chem; 2021; 296():100227. PubMed ID: 33361158
[TBL] [Abstract][Full Text] [Related]
8. Nav1.7-A1632G Mutation from a Family with Inherited Erythromelalgia: Enhanced Firing of Dorsal Root Ganglia Neurons Evoked by Thermal Stimuli.
Yang Y; Huang J; Mis MA; Estacion M; Macala L; Shah P; Schulman BR; Horton DB; Dib-Hajj SD; Waxman SG
J Neurosci; 2016 Jul; 36(28):7511-22. PubMed ID: 27413160
[TBL] [Abstract][Full Text] [Related]
9. A Nav1.7 channel mutation associated with hereditary erythromelalgia contributes to neuronal hyperexcitability and displays reduced lidocaine sensitivity.
Sheets PL; Jackson JO; Waxman SG; Dib-Hajj SD; Cummins TR
J Physiol; 2007 Jun; 581(Pt 3):1019-31. PubMed ID: 17430993
[TBL] [Abstract][Full Text] [Related]
10. Dynamic-clamp analysis of wild-type human Nav1.7 and erythromelalgia mutant channel L858H.
Vasylyev DV; Han C; Zhao P; Dib-Hajj S; Waxman SG
J Neurophysiol; 2014 Apr; 111(7):1429-43. PubMed ID: 24401712
[TBL] [Abstract][Full Text] [Related]
11. A Novel SCN9A Mutation (F826Y) in Primary Erythromelalgia Alters the Excitability of Nav1.7.
Wu B; Zhang Y; Tang H; Yang M; Long H; Shi G; Tang J; Shi X
Curr Mol Med; 2017; 17(6):450-457. PubMed ID: 28990532
[TBL] [Abstract][Full Text] [Related]
12. Mexiletine as a treatment for primary erythromelalgia: normalization of biophysical properties of mutant L858F NaV 1.7 sodium channels.
Cregg R; Cox JJ; Bennett DL; Wood JN; Werdehausen R
Br J Pharmacol; 2014 Oct; 171(19):4455-63. PubMed ID: 24866741
[TBL] [Abstract][Full Text] [Related]
13. Genetic, electrophysiological, and pathological studies on patients with SCN9A-related pain disorders.
Yuan JH; Cheng X; Matsuura E; Higuchi Y; Ando M; Hashiguchi A; Yoshimura A; Nakachi R; Mine J; Taketani T; Maeda K; Kawakami S; Kira R; Tanaka S; Kanai K; Dib-Hajj F; Dib-Hajj SD; Waxman SG; Takashima H
J Peripher Nerv Syst; 2023 Dec; 28(4):597-607. PubMed ID: 37555797
[TBL] [Abstract][Full Text] [Related]
14. Gain-of-function mutation of a voltage-gated sodium channel Na
Tanaka BS; Nguyen PT; Zhou EY; Yang Y; Yarov-Yarovoy V; Dib-Hajj SD; Waxman SG
J Biol Chem; 2017 Jun; 292(22):9262-9272. PubMed ID: 28381558
[TBL] [Abstract][Full Text] [Related]
15. Anomalous enhancement of resurgent Na
Huang CW; Lai HJ; Huang PY; Lee MJ; Kuo CC
Sci Rep; 2019 Aug; 9(1):12251. PubMed ID: 31439884
[TBL] [Abstract][Full Text] [Related]
16. Deletion mutation of sodium channel Na(V)1.7 in inherited erythromelalgia: enhanced slow inactivation modulates dorsal root ganglion neuron hyperexcitability.
Cheng X; Dib-Hajj SD; Tyrrell L; Te Morsche RH; Drenth JP; Waxman SG
Brain; 2011 Jul; 134(Pt 7):1972-86. PubMed ID: 21705421
[TBL] [Abstract][Full Text] [Related]
17. Depolarized inactivation overcomes impaired activation to produce DRG neuron hyperexcitability in a Nav1.7 mutation in a patient with distal limb pain.
Huang J; Yang Y; Dib-Hajj SD; van Es M; Zhao P; Salomon J; Drenth JP; Waxman SG
J Neurosci; 2014 Sep; 34(37):12328-40. PubMed ID: 25209274
[TBL] [Abstract][Full Text] [Related]
18. The G1662S NaV1.8 mutation in small fibre neuropathy: impaired inactivation underlying DRG neuron hyperexcitability.
Han C; Vasylyev D; Macala LJ; Gerrits MM; Hoeijmakers JG; Bekelaar KJ; Dib-Hajj SD; Faber CG; Merkies IS; Waxman SG
J Neurol Neurosurg Psychiatry; 2014 May; 85(5):499-505. PubMed ID: 24006052
[TBL] [Abstract][Full Text] [Related]
19. Novel
Sun J; Li L; Yang L; Duan G; Ma T; Li N; Liu Y; Yao J; Liu JY; Zhang X
Mol Pain; 2020; 16():1744806920923881. PubMed ID: 32420800
[TBL] [Abstract][Full Text] [Related]
20. Nav1.7 mutations associated with paroxysmal extreme pain disorder, but not erythromelalgia, enhance Navbeta4 peptide-mediated resurgent sodium currents.
Theile JW; Jarecki BW; Piekarz AD; Cummins TR
J Physiol; 2011 Feb; 589(Pt 3):597-608. PubMed ID: 21115638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]